We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016

By LabMedica International staff writers
Posted on 04 Aug 2016
In active demonstrations and static displays, several automated solutions for diagnostics laboratories and manufacturers are being presented by Festo (Hauppauge, NY, USA, and Esslingen am Neckar, Germany) at the 2016 AACC Annual Meeting & Clinical Lab Expo (July 31 - August 4; Philadelphia, PA, USA).

Equipment manufacturers partnering with Festo typically bring products to market faster. More...
As a case in point, Rheonix, Inc. representatives will be in the Festo booth discussing the impact of Festo automation and productivity programs on the development of the company’s EncompassMDx system – a one-stop solution for molecular diagnostic assays. The EncompassMDx automates sample preparation designed to isolate DNA and RNA from a variety of samples. Its detection capabilities combine the capacity of a microarray with the speed and resolution of qPCR in one unit.

In collaboration with New York University College of Dentistry (NYUCD), Rheonix has received funding to develop a rapid diagnostic capability for the Zika virus. The grant will allow the Rheonix/NYUCD team to pursue development of a fully automated screening and self-confirming assay that will simultaneously detect and confirm the presence of Zika virus in a single small sample of saliva or blood. The proposed approach builds upon previous success in which the Rheonix/NYUCD team developed a dual assay for simultaneous detection of HIV antibodies and viral RNA in a single specimen.

One of a number of Festo systems on display is EXCM – a handling system for clinical automation as a compact benchtop Cartesian robot. An active demonstration features the Mini-H gantry with a Z telescope slide axis for microfluidic dosing. Another demonstration simulates the transfer of whole blood from the specimen to an analysis chip within a small footprint device. In this demo, a gripper removes a vial from a tray and transfers it to an integrated rotary gripping unit. The system’s camera reads a barcode and approves eligibility for testing. This demo features the Festo CPX control system, which reduces the complexity of control and motion integration.

Festo also highlights the Single Axis Variable Pitch Module (SVPM) with up to 8 pipettes – it can aspirate or dispense from a 96 well plate, then expand to a different pitch to aspirate or dispense into a large variety of fluid containers such as tubes, chips, or vials.

The AquaJellies from the Festo Bionic Learning Network are artificial, autonomous jellyfish with electric drives and intelligent, adaptive mechanical systems. AACC attendees will see the bionic jellyfish in their new 500 gallon/1,900 liter tank. The movements of the AquaJellies come as close as possible to simulating jellyfish undulating through the world’s oceans. The integrated communication and sensor technology plus the real-time diagnostics enable coordinated, collective behavior among AquaJellies even in a limited space.

Related Links:
Festo



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.